Transcription of Hemoglobinopathies: Current Practices for Screening ...
{{id}} {{{paragraph}}}
hemoglobinopathies : Current Practices for Screening , Confirmation and Follow-upDECEMBER 2015 ASSOCIATION OF PUBLIC HEALTH LABORATORIES 21 hemoglobinopathies : Current Practices for Screening , Confirmation and Follow-upASSOCIATION OF PUBLIC HEALTH LABORATORIES 2 The mark CDC is owned by the US Dept. of Health and Human Services and is used with permission. Use of this logo is not an endorsement by HHS or CDC of any particular product, service, or publication was supported by Cooperative Agreement # U60HM000803 funded by the Centers for Disease Control and Prevention. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC or the Department of Health and Human Center for Immunization and Respiratory Diseases (IP)Office of Surveillance, Epidemiology and Laboratory Services (OSELS)National Center for HIV, Viral Hepatitis, STDs and TB Prevention (PS)National C
Regardless of an α-globin or β-globin variant, severity of disease can range from insignificant to serious or life threatening.2,3,4,5 Therefore, early detection through newborn screening is paramount.6,7 Hemoglobinopathies, specifically HbSS, HbS/β-thalassemia and HbSC disease were added to the Recommended Uniform Screening Panel (RUSP) in ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}